Archive
Oct 16, 2007
Ad hoc: Evotec Reports Positive Top-Line Results in Phase II Study with EVT 201 in Elderly Insomniacs with Daytime Sleepiness
Sep 19, 2007
Ad hoc: Evotec to Acquire Renovis, Seek NASDAQ Listing
Sep 10, 2007
Ad hoc: Evotec Sells its Chemical Development Business to Aptuit for GBP 31.5m (approx. EUR 46.4m) in Cash
Jun 04, 2007
Ad hoc: Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201
Mar 29, 2007
Ad hoc: Evotec to Acquire Neuro3d